1. Home
  2. ARDX vs ARCB Comparison

ARDX vs ARCB Comparison

Compare ARDX & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.80

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$69.83

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
ARCB
Founded
2007
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
ARCB
Price
$5.80
$69.83
Analyst Decision
Strong Buy
Buy
Analyst Count
10
11
Target Price
$10.65
$90.91
AVG Volume (30 Days)
2.7M
333.9K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
0.69%
EPS Growth
N/A
N/A
EPS
N/A
4.20
Revenue
$398,234,000.00
$4,039,115,000.00
Revenue This Year
$22.71
N/A
Revenue Next Year
$27.81
$3.87
P/E Ratio
N/A
$16.56
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$55.19
52 Week High
$6.78
$113.74

Technical Indicators

Market Signals
Indicator
ARDX
ARCB
Relative Strength Index (RSI) 53.23 56.47
Support Level $5.73 $61.56
Resistance Level $6.20 $73.32
Average True Range (ATR) 0.29 2.73
MACD 0.01 1.07
Stochastic Oscillator 57.78 73.22

Price Performance

Historical Comparison
ARDX
ARCB

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: